Reactive microglia are associated with nearly all neurodegenerative diseases 1 , but the mechanisms underlying microglia activation and their potential contributions to disease progression remain poorly understood. In contrast with Parkinson's and Alzheimer's diseases, which are related to a spectrum of genetic mutations and environmental factors 2,3 , HD is a neurodegenerative disorder caused by specific expansion of a CAG repeat in the coding region of the HTT gene 4 . This mutation results in an elongated stretch of glutamine near the N terminus of HTT 4 . Polyglutamine expansions of more than 37 residues initiate a degenerative process that is characterized by the loss of medium spiny neurons in the striatum 5 . A number of roles of this protein have been uncovered, but the precise mechanism(s) by which mHTT causes dysfunction and degeneration of neurons remains an area of intense research.
Reactive microglia are associated with nearly all neurodegenerative diseases 1 , but the mechanisms underlying microglia activation and their potential contributions to disease progression remain poorly understood. In contrast with Parkinson's and Alzheimer's diseases, which are related to a spectrum of genetic mutations and environmental factors 2, 3 , HD is a neurodegenerative disorder caused by specific expansion of a CAG repeat in the coding region of the HTT gene 4 . This mutation results in an elongated stretch of glutamine near the N terminus of HTT 4 . Polyglutamine expansions of more than 37 residues initiate a degenerative process that is characterized by the loss of medium spiny neurons in the striatum 5 . A number of roles of this protein have been uncovered, but the precise mechanism(s) by which mHTT causes dysfunction and degeneration of neurons remains an area of intense research.
Although HD is thought to be primarily caused by mutant protein expression in neurons, HTT is broadly expressed, including high levels of expression in microglia 6, 7 . Despite the fact that microglia comprise <10% of the total brain cells 8 , this specialized cell population rapidly responds to even minor pathological changes in the brain and may contribute directly to neuronal degeneration by producing an excess of various pro-inflammatory factors 9 . Several lines of evidence point to altered microglia activation states in the context of HD. Inflammation appears early in the onset of disease 10 and reactive microglia are conspicuous even in low-grade HD human brains, suggesting an early microglia response to changes in axons 11 . In patients' striatum and cortex, reactive microglia occur in all grades of pathology and accumulate in relation to the degree of neuronal loss 11 . Furthermore, an in vivo PET study showed that microglia activation correlates with the severity of the pathology in HD patients 12 . Substantial microglia activation in regions related to cognitive function in HD patients has recently been suggested to predict disease onset 13 . Monocytes from HD subjects express mHTT and have been reported to be hyperactive in response to stimulation 14 . A similar pattern was seen in macrophages and microglia derived from R6/2 (ref. 15) and YAC 14 HD mouse models. Notably, age-dependent changes in striatal microglial morphology and vasculature in the YAC128 mouse model of HD have been reported 16 . The cerebrospinal fluid and striatum of HD patients exhibit evidence of immune activation, with upregulation of IL6, IL8 and TNFα 14, 17 . These cytokines can induce a CNS inflammatory response that alters the blood brain barrier and affects neuronal function 18 , suggesting that they could contribute to disease progression. At a molecular level, dysfunctional kynurenine pathway 19 , NFκB activation 20 , cannabinoid receptor 2 signaling 21 and P2X7 receptor involvement 22 have been reported as potential mechanisms explaining HD inflammation in different mouse models.
Inflammation is normally an adaptive biological response to pathogen infection and tissue injury that serves to engage the immune system and tissue repair mechanisms. In these cases, inflammation resolves following eradication of the inciting stimulus. However, when pathological processes result in a sustained inflammatory response, persistent expression of mediators such as IL6, IL8 and TNFα can contribute to tissue damage and disease progression 23 . The observation of an inflammatory component of HD raises the question of whether inflammation is the response of surrounding cells to a RESULTS mHTT promotes pro-inflammatory gene expression To investigate potential cell-autonomous roles of mHTT in microglia, we generated isogenic BV2 microglia cell lines stably overexpressing the first 548 amino acids of the N terminus of human HTT or mHTT. These lines were maintained as pools of clones and cultured for 4 weeks before study to avoid acute effects of lentiviral infection on microglia activation. Deep sequencing revealed that microglia expressing mHTT N548 exhibited higher expression of mRNAs encoding pro-inflammatory factors as compared with cells expressing wild-type HTT N548 in the absence of pro-inflammatory stimulation ( Fig. 1a and Supplementary Table 1) . Notably, the increase in Il6 and Tnf mRNA (Fig. 1b,c) was similar to the pattern previously observed in HD patients 14, 17 . Expression of Spi1 (encoding PU.1), a key factor in myeloid fate determination 9, [24] [25] [26] , was itself upregulated in the presence of mHTT N548 at the mRNA (Fig. 1d) and protein (Fig. 1e ) levels. Conversely, in the presence of HTT N548, the expression of PU.1 was downregulated (Fig. 1e) . Gene Ontology analysis of the entire set of upregulated genes, observed in presence of mHTT N548, indicated significant enrichment for terms related to innate immunity and inflammation (P < 1 × 10 −15 ; Fig. 1f) . Control npg a r t I C l e S To investigate potential mechanisms leading to the enhanced inflammatory gene expression in microglia expressing mHTT N548, we performed de novo motif enrichment analysis of transcriptional regulatory elements associated with the upregulated genes. Consistent with the upregulation of PU.1 expression, we observed a consensus PU.1 motif as the most enriched regulatory element in the enhancers and promoters of the upregulated genes in microglia cells expressing mHTT N548 (Fig. 2a) . A binding motif for NFκB was the next most enriched motif, consistent with a previously described activation of this factor in presence of mHTT 20 . Given that PU.1 is a key factor in myeloid fate determination 9, 25 and is required for selection of enhancers that are acted on by NFκB 24 , these findings suggested a potential role of mHTT in priming myeloid cells toward inflammatory activation.
To establish a direct link between the increased expression of PU.1 and target genes, we performed chromatin immunoprecipitation coupled to deep sequencing (ChIP-Seq) to quantify PU.1 binding in BV2 microglia cells overexpressing either HTT N548 or mHTT N548. In addition, we performed ChIP-Seq analysis for H3K4me2, a histone modification associated with enhancers and promoters [27] [28] [29] , thereby generating a microglia enhancer 'atlas' . In BV2 microglia expressing HTT N548, PU.1 was associated with approximately half of the H3K4me2-marked regions, consistent with the binding pattern of PU.1 in macrophages 24, 30 (Fig. 2b) . PU.1 peaks in microglia expressing HTT N548 or mHTT N548 largely overlapped, but mHTT N548 expression was associated with a significant number of differential PU.1 peaks (defined by a normalized tag count of >4-fold comparing mHTT N548 to HTT N548), consistent with the increased expression of PU.1 (2,634 differential sites in mHTT N548 cells versus 397 differential sites in HTT N548 cells, P < 10 −4 ; Fig. 2c) .
Genomic loci encoding mRNAs that were upregulated in BV2 microglia expressing mHTT N548 generally exhibited higher enrichment of PU.1 binding to promoters and enhancers, exemplified by the Tnf locus (Fig. 2d) . However, a subset of PU.1 target genes, exemplified by Il6, did not exhibit this pattern (Fig. 2d) . This raised the question as to whether additional factors might cooperate with PU.1 to contribute to the observed upregulation of PU.1 target genes. De novo motif analysis of PU.1 binding sites in the vicinity of genes upregulated in the presence of mHTT N548 returned a motif for the C/EBP family of transcription factors (Fig. 2e) . Members of the C/EBP family are required for myeloid cell development and induction of several inflammatory mediators 31, 32 . To investigate a potential role of C/EBPs in contributing to expression of a subset of PU.1 target genes, we performed ChIP-Seq analysis for C/EBPα and C/EBPβ in BV2 microglia cells overexpressing HTT N548 or mHTT N548. Notably, we observed a stronger enrichment for C/EBPα and C/EBPβ on the Il6 promoter/enhancer, as well as on npg a r t I C l e S N548 cells (Fig. 2f) . No differences in Cebpa and Cebpb mRNA expression levels were observed in microglia overexpressing wild-type or mHTT N548 (Supplementary Table 1 ). Motif enrichment analysis for C/EBPβ ChIP-Seq confirmed the correlation between this factor and PU.1 binding (Fig. 2g) . Analysis of the correlation between the distance from promoter to the nearest C/EBPβ peak, as well as from promoter to the nearest PU.1 peak detected by ChIP-Seq and the altered gene expression in the presence of mHTT N548, indicated a higher correlation for C/EBPβ binding and PU.1 binding (10 −33 and 10 −26 , respectively) to induced genes in comparison with the total set of expressed genes (Fig. 2h) . Nearly 80% of the upregulated genes in mHTT N548-expressing cells exhibited PU.1 and/or C/EBPβ binding within 5 kb of the transcriptional start site (Fig. 2i) . In contrast, the corresponding frequency for all genes was ~51%. Together, these findings indicate a strong relationship of nearby PU.1 and C/EBPβ binding to upregulated genes in mHTT N548-expressing cells. To confirm and extend the observations obtained from microglia cell lines overexpressing mHTT N548, we next measured the expression of Spi1 (PU.1) and representative PU.1-C/EBPs target gene mRNAs in primary microglia derived from the R6/2 mouse model 33 expressing mHTT (exon 1), in the absence of pro-inflammatory stimulation. Spi1 expression was significantly increased in primary microglia derived from newborn R6/2 mice, both at mRNA (+50% increase, P < 0.0009, two-tailed paired Student t test) and protein levels ( Fig. 3a) , in comparison with primary microglia from non-transgenic littermates. Corresponding increases were observed in the expression of Il6 (threefold increase, P = 0.0035, two-tailed paired Student t test) and Tnf mRNAs (twofold increase, P = 0.0075, two-tailed paired Student t test). In contrast, increased expression of Spi1, Il6 and Tnf was not observed in bone marrow-derived macrophages (BMDMs) from R6/2 mice ( Supplementary Fig. 1a-c) . We found no difference in Cebpa and Cebpb mRNA expression in primary microglia and BMDMs from R6/2 and nontransgenic littermates (data not shown). Thus, the observed increase of Spi1 expression seems to be specific for primary microglia expressing mHTT (exon 1). Supernatants collected from the same R6/2 primary microglia cultures exhibited significantly increased (P < 0.0001) IL6 levels after 72 h of incubation, confirming the increased Il6 mRNA expression observed in the same cells (Fig. 3b) .
To investigate whether PU.1 and C/EBPα and C/EBPβ are required for controlling the enhanced pro-inflammatory gene expression that we observed in presence of mHTT (exon 1), we transfected primary microglia from R6/2 and non-transgenic littermates with specific siRNAs directed against Cebpa, Cebpb or Spi1. The three siRNAs effectively reduced the expression of their target mRNAs by ~80% in comparison with control siRNAs (Supplementary Fig. 2 ). Knockdown of Cebpa, Cebpb and Spi1 separately greatly reduced the levels of mRNA expression of Il6 and Tnf in primary microglia from R6/2 in comparison with microglia transfected with control siRNA (Fig. 3c,d ). These data confirm the requirement of PU.1 and C/EBPs for increased expression of these pro-inflammatory mediators in cells expressing mHTT (exon 1) in the absence of pro-inflammatory stimulation.
mHTT promotes activation of microglia, but not BMDM To extend these studies to a mouse model that is genetically analogous to human HD, we took advantage of a knock-in model characterized by a 175 CAG expansion in the Htt (Hdh) gene 34 . We evaluated Spi1 mRNA and protein expression as well as the expression of representative PU.1-C/EBPs target genes in primary microglia derived from newborn (P0) wild-type, heterozygous and homozygous mHTT knock-in mice. We observed that Spi1 was significantly upregulated in primary microglia from mice homozygous for mHTT (Q175/Q175), both at the mRNA and protein level (Fig. 4a) , in comparison with wild-type HTT-expressing primary microglia cells (Q7/Q7). Consistently, mRNAs from PU.1-C/EBPs target genes Il6, Tlr2 and Irf1 were upregulated in primary microglia from homozygous mutant mice in the absence of pro-inflammatory stimulation (Fig. 4b) . Furthermore, we performed RNA-Seq analysis of microglia derived from wild-type and knock-in Hdh 175/175 adult symptomatic mice. We verified that the expression of full-length mHTT in vivo in microglia was able to promote a genomewide pro-inflammatory transcription signature similar to that observed in a microglia cell line expressing the N terminus fragment of mHTT ( Fig. 4c and Supplementary Table 2) .
Compatible with the observation of an increased activity of the myeloid lineage determining factors PU.1-C/EBPs, we also observed . siRNA C-is a nontargeting negative control. In all cases, P values were calculated using the two-tailed paired Student t test. Each experiment is representative of at least three independent replicates. npg a r t I C l e S an enrichment for cell proliferation and myeloid differentiation genes in the GO analysis (Fig. 4c) . Although the vast majority of HD patients only carry a single allele of mHTT, alterations in gene expression observed in microglia from homozygous Hdh 175/175 mice were less obvious in microglia from heterozygous mice. This finding suggests that genetic background, environmental factors, cellular context and age are important for determining penetrance of the mutant allele. Consistent with this, we performed RNA-Seq analysis of BMDMs obtained from the same mice (Supplementary Table 2 ). The analysis of the transcriptional profiles of BMDMs from wild-type and knock-in Hdh 175/175 mice revealed that the expression of Q175/Q175 did not produce the same pro-inflammatory transcriptional activation in BMDMs as we observed in microglia from the same mice (Fig. 4c) , most likely reflecting both different origins 35, 36 and environmental influences. As further proof of this, global RNASeq analysis of wild-type microglia and BMDMs clearly showed a substantial difference between the two myeloid cell populations in term of basal gene expression programs (Supplementary Fig. 3 ).
Pro-inflammatory transcription is specific for mHTT in vivo
To link the observations obtained ex vivo in primary microglia from different mouse models of HD with the disease progression in vivo, we evaluated the expression of Spi1 and its pro-inflammatory target genes in adult R6/2 mice in comparison with non-transgenic littermates. Increased expression of Spi1 mRNA was already evident in pre-symptomatic mice and was even greater at symptomatic stage in striatum from R6/2 mice (Supplementary Fig. 4a ). Concomitantly, we detected an increase in the expression of Il6, Tnf, Irf1 and Tlr2 mRNA in the same region ( Supplementary Fig. 4b-e) . No difference in the levels of Cebpa or Cebpb mRNA expression was observed in striatum from R6/2 and nontransgenic littermates (data not shown). The levels of Spi1 expression as well as the pro-inflammatory gene expression correlated with the disease progression in the R6/2 model of HD. In parallel, we analyzed the expression of PU.1 and specific PU.1-C/EBPα and C/EBPβ target pro-inflammatory genes in spinal cord, cortex and striatum of SOD1 G37R mice, an animal model for amyotrophic lateral sclerosis (ALS) 37 . ALS is also a progressive neurodegenerative disease that primarily affects motor neurons that connect the brain and spinal cord to muscles, resulting in a fatal paralysis a few years after onset 38 . Even though microglia activation is important for ALS pathogenesis 39 , PU.1 and specific PU.1-C/EBPα and C/EBPβ target pro-inflammatory genes that were elevated in mutant Huntingtin models were not increased in striatum, cortex or spinal cord from 1-year-old symptomatic SOD1 G37R mice ( Supplementary Fig. 5a-e) . These results are consistent with a specific, cell-autonomous role of mHTT in promoting basal activation of pro-inflammatory genes via the lineage-determining factors PU.1, C/EBPα and C/EBPβ.
Enhanced pro-inflammatory transcription in HD brains
We next investigated the expression of SPI1 (PU.1), CEBPA and CEBPB, as well as their targets in striatum, cortex and monocytes from human HD and control individuals. SPI1 expression was increased in striatal as well as in cortical post-mortem human samples from HD individuals, in concert with increased levels of IL6, IRF1 and TLR2 mRNAs in the striatum and a trend increase of IL6, TNF and TLR2 in the cortex of the HD individuals (Fig. 5a-c and Supplementary  Fig. 6a,b) . No changes in CEBPA and CEBPB mRNAs levels were detected in cortical or striatal samples from HD individuals in comparison with matching controls (data not shown). The expression of SPI1, CEBPA and CEBPB, as well as their target genes, showed no substantial difference in monocytes from HD patients (Fig. 5a-c and Supplementary Fig. 6a,b) . These observations confirm and extend the distinct inflammatory profile that has been observed in postmortem HD brains 14, 17 . We next performed immunostaining for PU.1 in frontal cortex as well as in striatum of five frozen post-mortem samples from HD individuals and matching controls (Fig. 5d) . We observed an increase in the number of microglia per section (Fig. 5d) , consistent with previous observations 11 . Quantification of the intensity and distribution of PU.1 staining further revealed a significant increase in PU.1 expression on a per cell basis (~2-fold, P = 0.018 in the striatum and ~2-fold, P = 0.0013 in the cortex; Fig. 5e ). These in vivo findings in the brains of patients with HD are therefore consistent with what we observed in primary microglia expressing mHTT isolated from two different rodent models as well as in BV2 microglia expressing mHTT N548. 40 . We recently reported that reduced Nurr1 expression results in exaggerated inflammatory responses in microglia, leading to the production of factors that cause death of tyrosine hydroxylase-expressing neurons 41 . Given that we observed exaggerated IL6 secretion by mHTT (exon 1)-expressing microglia (Fig. 3b) , we investigated whether neuron-microglia co-culture would exhibit any neurotoxic effects of microglia expressing mHTT on wild-type neurons. This possibility was evaluated by co-culturing mouse embryonic stem cell-derived normal neurons over a substrate of wild-type primary astrocytes. Subsequently, wild-type (Q7/Q7) or mHTT knock-in microglia (Q175/Q175) cells were added to the culture. The addition of mHTT-expressing microglia, but not wild-type microglia, increased neuronal apoptosis (Fig. 6a) .
To extend these observations in vivo, we considered the possibility that sterile inflammation could be triggered in HD patients by endogenous molecules, such as DAMPs, components of dead neurons and protein aggregates. As a means of mimicking sterile inflammation, we performed stereotactic injection of lipopolysaccharide (LPS) into the striatum of 12-15-week-old wild-type or Hdh 175/175 mice. Given the fact that LPS mainly triggers microglia activation, but has no direct toxic effect on neurons 40 , LPS-induced neurotoxicity is secondary to microglia activation. No difference was detected in the number of degenerating neurons in wild-type versus Hdh 175/175 mice injected with saline solution as measured by Fluoro-Jade B staining. This result is consistent with the lack of HD symptoms or CNS pathology in Hdh 175/175 mice at this age 42 . In contrast, LPS induced greater neuronal death in Hdh 175/175 mice than in wild-type mice (Fig. 6b) . As a negative control, no Fluoro-Jade B + cells were detected in the contralateral non-injected hemispheres. This result is consistent with exaggerated inflammatory and neurotoxic responses of microglia expressing mHTT, but does not exclude the possibility that this was also a result of increased sensitivity of neurons expressing mHTT. To directly address this concern, we mated a mouse expressing the a r t I C l e S myeloid-specific Cre driver (Cx3cr1-Cre) to RosaHD knock-in mice 43 ( Fig. 7a) , which resulted in exclusive microglia-specific expression of mHTT (exon 1) in the brain (Fig. 7b) . Expression of the mHTT (exon 1) in microglia was sufficient to induce an increase in the transcription of Spi1, Il6 and Tnf mRNAs in the striatum of RosaHD × Cx3cr1-Cre mice in comparison with nontransgenic littermates (Fig. 7c) . We used these and control mice to determine whether expression of mHTT (exon 1) selectively in microglia among brain cells results in exaggerated neuronal death following an inflammatory insult. We performed stereotactic injection of LPS into the striatum of 8-week-old RosaHD × Cx3cr1-Cre and nontransgenic littermates mice. We found that mice expressing mHTT (exon 1) in microglia showed an enhanced incidence of neuronal death in the presence of sterile inflammation in comparison with nontransgenic littermates (Fig. 7d) . Taken together, these results demonstrate a potential contribution of microglia activation and inflammation to HD pathogenesis.
DISCUSSION
Previous studies of the inflammatory component of HD have provided evidence for alterations of signal-dependent mechanisms in the brains of HD mouse models, including NFκB activation 20 , cannabinoid receptor 2 signaling 21 and P2X7 receptor involvement 22 . We found that the expression of mHTT specifically in microglia was sufficient to confer a cell-autonomous increase in pro-inflammatory gene expression and exaggerated neurotoxic effects on wild-type neurons ex vivo and after pro-inflammatory stimulation in vivo. Several lines of evidence support a mechanism in which mHTT exerts a cellautonomous effect in microglia by increasing the expression and transcriptional activities of the myeloid lineage-determining factors PU.1, C/EBPα and C/EBPβ. Binding sites for PU.1 and C/EBPs were highly enriched in enhancers and promoters associated with the genes exhibiting constitutive upregulation in mHTT-expressing microglia. Expression of PU.1 itself was increased at both the mRNA and protein levels in mHTT-expressing microglia, and ChIP-Seq analysis demonstrated enhanced binding of PU.1 at thousands of genomic locations in these cells. Increased binding of PU.1 was associated with enhanced co-occupancy by C/EBPs, and the combination of enhanced PU.1 and C/EBP binding was highly correlated with increased expression of nearby genes, such as Il6 and Tnf. Furthermore, given that PU.1, C/EBPα and C/EBPβ are lineage-determining factors, we could speculate that their increased activity in mHTT-expressing microglia and the concomitant enrichment for cell proliferation and myeloid differentiation genes in the GO analysis could be implicated in the increased density of microglia observed in HD individuals 11 . Recent studies have suggested that PU.1, C/EBPs and AP-1 proteins function in a collaborative manner to select a large fraction of the 26 (Supplementary Fig. 7) . Of particular relevance to our findings, increased expression of a conditional form of PU.1 resulted in a coordinate increase in PU.1, C/EBPα and C/EBPβ binding throughout the genome, without changes in C/EBPα and C/EBPβ expression 26 . Our previous studies demonstrated that enhancers selected by PU.1 and C/EBPs provide access to signaldependent factors such as nuclear receptors and NFκB, providing the basis for cell-specific responses 26 . Our findings are therefore consistent with a model in which mHTT-induced PU.1 expression drives the selection PU.1-C/EBPs-dependent enhancers that promote expression of pro-inflammatory/neurotoxic mediators in microglia under basal conditions (Supplementary Fig. 7) . Eventually, sterile inflammation triggered in HD patients by endogenous molecules, such as components of dead neurons and protein aggregates, could lead to a further microglia activation and result in an increased neuronal death (Supplementary Fig. 7 ). This mechanism would explain both increases in basal gene expression and enhanced responses to exogenous stimuli and suggests a molecular basis for the state of priming defined recently on the basis of morphological evidence 16 .
Our findings are consistent with the possibility that exaggerated microglia activation could contribute to the early inflammatory reaction observed in HD 11, 16, 44 . In particular, we observed that primary microglia derived from R6/2 mice constitutively express and secrete increased amounts of the pro-inflammatory cytokine IL6. Although a previous study did not find evidence for IL6 secretion by microglia from R6/2 mice in absence of stimulation 14 , this apparent discrepancy with our data can easily be explained by the fact that we used a more sensitive detection system than that used in the previous study. Our results provide a potential explanation for previous observations of increased IL6 in the cerebrospinal fluid of HD patients before the clinical onset of disease 45 . Moreover, it has been suggested that microglia can modulate adult neurogenesis, such as when activated by inflammation 46 . IL6 appears to be one of the key mediators of this anti-neurogenic effect 47 . This abnormal IL6 secretion, reported here and by others 14, 17 , could also help to explain the impaired neurogenesis that has been reported in several mouse models of HD [48] [49] [50] .
In addition to conferring a cell-autonomous basal increase in expression of pro-inflammatory and neurotoxic mediators, our findings suggest that expression of mHTT in microglia also confers increased sensitivity to extrinsic inducers of inflammation. Because microglia are the primary cells capable of responding to LPS in the brain parenchyma, the observation that Hdh 175/175 mice exhibited increased neuronal apoptosis following LPS injection is consistent with exaggerated neurotoxic responses of Hdh 175/175 microglia on wild-type neurons ex vivo. The in vivo observation from Hdh 175/175 mice could be explained in part by the fact that neurons expressing mHTT are more fragile than normal neurons and therefore more sensitive to the toxic effect induced by mHTT microglia. In our opinion, the in vivo experiment might reflect what could happen in HD patients, where cell-autonomous microglia hyper-activation coupled with neuronal fragility can concur to promote disease progression. Nevertheless, the experiment conducted on mice expressing mHTT (exon 1) in microglia clearly showed that microglia activation in HD is sufficient to promote neuronal degeneration and can have a potential contribution to the pathogenesis of the disease. However, further studies will be required to establish whether selective expression of mHTT in microglia is sufficient to exert neuropathological and behavioral deficits in mice.
In the context of HD, what seems to be a general transcriptional mechanism underlying macrophage and possibly microglia activation appears to be specifically related to the expression of mHTT exclusively in microglia. In fact, the PU.1-C/EBPs-dependent enhanced basal pro-inflammatory genes expression was not observed in the CNS of an animal model for ALS carrying a mutation in the Sod1 gene. This result is particularly relevant considering that ALS is a progressive neurodegenerative disease in which microglia activation has a key role in pathogenesis 39 Notably, the effects of mHTT on PU.1-dependent programs of gene expression appeared to be microglia specific, as we found no differences in PU.1 levels or pro-inflammatory gene expression in BMDMs obtained from R6/2 and Hdh 175/175 mice or monocytes from HD individuals. The basis for specific effects of mHTT on microglia gene expression is unclear, but recent lineage tracing experiments provide evidence that microglia are derived from fetal yolk sac progenitors very early in development and represent a self-renewing population of cells that is independent of BMDMs 35, 41 . It is therefore possible that either this unique origin or the specific differentiation program conferred by residence in the CNS determines the cell-autonomous functions of mHTT in microglia. Collectively, our findings reveal a previously unknown and unexpected role of mHTT in disrupting the regulation of microglia identity and function and provide further impetus to better understand the contribution of microglia activation to the pathogenesis of HD.
METHODS
Methods and any associated references are available in the online version of the paper. a r t I C l e S comPeTIng FInAncIAl InTeReSTSfor 1 min each. Then, slides were incubated in 0.06% KMnO 4 (wt/vol) for 5 min and washed in H 2 O for 1 min. Fluoro-Jade B (liquid stock solution, 0.01%, wt/vol) was added to the slides and left to incubate for 30 min. Finally, after washing and drying overnight, slides were immersed in Neoclear and mounted on coverslip. 4,6-diamidino-2-phenylindole (DAPI, 1:1,000, Roche) was used to reveal nuclei. In the case of wild-type and Hdh 175/175 mice experiment, to determine the number of Fluoro-Jade B + degenerated/dead neurons, the number of double-positive cells (Fluoro-Jade B + and DAPI + ) were counted in six contiguous sections per mouse. In the case of RosaHD × Cx3cr1-Cre and nontransgenic littermates experiment, massive cell death was observed after LPS injection for both genotypes. Thus, to determine the number of Fluoro-Jade B + degenerated/dead neurons, the number of double-positive cells (Fluoro-Jade B + and DAPI + ) as well as the green puncta clusters within/surrounding DAPI nuclei were counted as positive in nine contiguous sections per each mouse. Scoring was performed by an investigator who was blind to the experimental conditions. Immunohistochemistry (IHc) and quantification. Post-mortem frozen brain samples (Brodmann area 4, caudate-putamen) were cryosectioned at 5 microns and used in the immunohistochemistry assays. Controls included sections of human spleen (control for macrophages), rabbit IgG (negative control), diluting buffer (1% BSA in PBS) and rabbit anti-Von Willebrand factor (blood vessel marker, positive control). Each step of the assay was followed by buffer rinses. Endogenous peroxidase was blocked with 0.03% (vol/vol) H 2 O 2 (Fisher # H325-100) for 30 min. Endogenous collagen was blocked with 1% BSA/PBS (Sigma #A4503G) for 30 min. Sections were fixed with 10% (vol/vol) neutral-buffered formalin (Fisher SF93-4) for 30 min, washed with PBS and overlaid with either rabbit IgG (1:100, Dako #N1699) or rabbit antibody to PU.1 (1:100, Cell Signaling #2266S) overnight in a humid chamber at 4 °C. Binding was detected using horseradish peroxidase-labeled antibody to rabbit (Jackson #111-035-144) at 1:500 for 30 min at 25 °C. Substrate color development was performed using the AEC kit (Vectorlab #H 5501). Nuclei were counterstained using Mayer's hematoxylin and slides were aqueous mounted for viewing and digital photomicrography using an Olympus BH2 microscope, equipped with a digital Magnafire camera. For quantification, five images for each sample were captured. To determine the intensity of signal, the number of pixels representing the area of PU.1 staining was calculated automatically using Magic Wand Tool (Adobe Photoshop). For each image, the number of PU.1+ microglia cells is represented by the number of noncontiguous areas in which PU.1 staining merging nuclear staining automatically revealed by the software. PU.1+ microglia cells were distinguished morphologically from endothelial cells.
RnA isolation and quantitative PcR. Total RNA was isolated by RNeasy kit (Qiagen) from BV2 cells, microglia, monocytes and BMDMs. Cortex and striatum from R6/2, SOD1 G37R , RosaHD × Cx3cr1-Cre mice as well as HD post-mortem brain samples were processed with Trizol (Invitrogen) to extract total RNA. 1 µg of total RNA was used for cDNA synthesis using Superscript III (Invitrogen), and quantitative PCR was performed with SYBR-GreenER (Invitrogen) detected by 7300 Real Time PCR System (ABI). The sequences of qPCR primers used for mRNA quantification in this study were obtained from PrimerBank 53 . For human samples, the results were normalized over expressed Alu repeats 54 .
western blotting. BV2 cells, primary microglia, astrocytes and neurons were lysed with buffer C (150 mM NaCl, 250 mM Tris HCl pH 7.5, 1% Triton X-100, 10% (vol/vol) glycerol, 5 mM EDTA, 1 mM EGTA) plus 1 mM PMSF, 1 mM DTT, Complete Protease Inhibitor Cocktail (Roche). Lysates were incubated in ice for 1 h. Finally, lysates were cleared by spinning at 4 °C at 13,000 rpm for 10 min. The protein concentrations in the supernatants were then determined using the BCA protein assay (Bio-Rad) as described by the manufacturers. A total of 100 µg of protein was separated by SDS-polyacrylamide electrophoresis using NuPAGE 4-12% bis-tris gel (Invitrogen), then transferred electrophoretically to a PVDF membrane. The membranes were blocked by incubation with 5% non-fat milk (wt/vol) in Tris-buffered saline containing 0.1% Tween-20 (vol/vol) (TBST) for 60 min at 25 °C. The membranes were then incubated overnight at 4 °C with primary antibody to PU.1 (1:1,000, sc-352, Santa Cruz), antibody to actin (1:10,000, CP01, Calbiochem), antibody to Histone H3 (1:1,000, Cell Signaling, #4620) and antibody to Polyglutamine (1:500, MAB1574, Millipore). The membranes were washed in TBST (3 × 5 min) before a 1-h incubation with peroxidase-linked secondary antibodies to rabbit or mouse accordingly at 25 °C. The immunoblots were then visualized using the enhanced chemiluminescence method (Amersham). elISA for Il6. IL6 quantification in cell culture supernatant have been performed with Mouse Interleukin-6 (IL6) ELISA kit from Thermo Scientific, according to manufacturer's instructions. chromatin immunoprecipitation (chIP). ChIP was performed as described previously 24 . Briefly, 20x10 6 cells were crosslinked in 1% formaldehyde/PBS for 10 min at 25 °C. After quenching the reaction by adding 125 mM glycine, we washed the cells twice with PBS and centrifuged them (8 min, 800 g, 4 °C). Cells were resuspended in swelling buffer (10 mM HEPES/KOH pH 7.9, 85 mM KCl, 1 mM EDTA, 0.5% (vol/vol) IGEPAL CA-630 by volume, 1× protease inhibitor cocktail (Roche), 1 mM PMSF) for 5 min. Cells were spun down and resuspended in 500 µl of lysis buffer (50 mM Tris-HCl pH 7.4, 1% SDS, 0.5% (vol/vol) EmpigenBB, 10 mM EDTA, 1× protease inhibitor cocktail (Roche), 1 mM PMSF) and chromatin was sheared to an average DNA size of 300-400 bp by administering five pulses of 10-s duration at 10-W power output with 30-s pause on ice using a Misonix 3000 sonicator. The lysate was cleared by centrifugation (5 min, 16,000 g, 4 °C), and supernatant was diluted 2.5-fold with 750-µl dilution buffer (20 mM Tris-HCl pH 7.4, 100 mM NaCl, 0.5% Triton X-100, 2 mM EDTA, 1× protease inhibitor cocktail; Roche). The diluted lysate was pre-cleared by rotating for 2 h at 4 °C with 120 µl 50% rProtein A Sepharose Fast Flow (GE Healthcare). The beads were discarded, and 1% of the supernatant was kept as ChIP input. The protein of interest was immunoprecipitated by rotating the supernatant with 2.5 µg antibody overnight at 4 °C, then adding 50 µl blocked rProtein A Sepharose and rotating the sample for an additional 1 h at 4 °C. The beads were pelleted (2 min, 1,000 g, 4 °C), the supernatant discarded, and the beads were transferred in 400 µl of wash buffer I (WBI: 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 2 mM EDTA) into 0.45-µm filter cartridges (Ultrafree MC, Millipore), spun dry (1 min, 2,200g, 4 °C), washed one more time with WBI, and twice each with WBII (20 mM Tris-HCl pH 7.4, 500 mM NaCl, 1% Triton X-100, 2 mM EDTA), WBIII (10 mM Tris-HCl pH 7.4, 250 mM LiCl, 1% IGEPAL CA-630, 1% (wt/vol) sodium deoxycholate, 1 mM EDTA), and TE. Immunoprecipitated chromatin was eluted twice with 100 µl of elution buffer each (100 mM NaHCO 3 , 1% SDS) into fresh tubes for 20 min. Eluates were pooled, the Na + concentration was adjusted to 300 mM with 5 M NaCl and crosslinks were reversed overnight at 65 °C in a hybridization oven. The samples were sequentially incubated at 37 °C for 2 h each with 0.33 mg ml −1 RNase A and 0.5 mg ml −1 proteinase K. The DNA was isolated using the QiaQuick PCR purification kit (Qiagen) according to the manufacturer's instructions. We used antibodies to PU.1 (sc-352), C/EBPα (sc-61), C/EBPβ (sc-150), control rabbit IgG (sc-2027) (Santa Cruz Biotech), H3K4me2 (cat#07-030, Millipore). For all antibodies, the working dilution was 1:1,000.
RnA sequencing. RNA was purified using RNeasy Mini Kit (Qiagen) and enriched for Poly(A)-RNA with MicroPoly(A) Purist Kit (Ambion). Subsequently, RNA was treated with TURBO DNase (Ambion), fragmented with RNA Fragmentation Reagents (Ambion) and purified by a P-30 column (Bio-Rad). Fragmented RNA was dephosphorylated with Antarctic phosphatase (New England Biolabs) heat inactivated and precipitated over-night. Poly(A)-tailing and cDNA synthesis was performed as previously described 55 . For reverse transcription, oligonucleotides with custom barcodes (underlined, slashes represent the four different bar codes) were used: 5′-Phos-CA/TG/AC/GT.GATCGTCGGACTGTAGAACTCT/idSp/ CAAGCAGAAGACGGCATACGATTTTTTTTTTTTTTTTTTTTVN-3′, where idSp represents the internal spacer 1′2′-dideoxyribose (dSpacer). Subsequently, exonuclease was used to remove the excess oligonucleotide. After heat inactivation, RNA was hydrolyzed by alkaline treatment (100 mM NaOH) and heat at 95 °C for 25 min. The cDNA fragments of 50-150 nucleotides were purified on a denaturing Novex 10% polyacrylamide TBE-urea gel (Invitrogen). The recovered cDNA was circularized, linearized, amplified for 12 cycles, and gel purified as previously described 55 . The library was sequenced on the Illumina HiSeq 2000 according to the manufacturer's instructions. Reads were aligned to the mouse mm9 genome (NCBI Build 37) using Tophat. RNA-Seq experiments were normalized and visualized using HOMER (http://homer.salk.edu/homer/) to generate custom tracks for the UCSC Genome Browser (http://genome.ucsc.edu/).
Gene expression values were generating for RefSeq annotated transcripts using HOMER and differential expression calculations were performed using edgeR 27 . Gene Ontology analysis was performed using DAVID (http://david. abcc.ncifcrf.gov/). Gene expression clustering was performed using Cluster 3.0 and visualized using Java TreeView. Promoters of regulated genes were analyzed for enriched motifs using HOMER 24 .
chIP-sequencing and data analysis. DNA from chromatin immunoprecipitation (10-50 ng) was adaptor-ligated and PCR amplified according to the manufacturer's protocol (Illumina). ChIP fragments were sequenced for 36 or 50 cycles on an Illumina HiSeq 2000 according to the manufacturer's instructions. Reads were aligned to the mouse mm9 genome assembly (NCBI Build 37) using Bowtie allowing up to two mismatches. Only tags that mapped uniquely to the genome were considered for further analysis. ChIP-Seq experiments were normalized and visualized by using HOMER (http://homer.salk.edu/homer/) to generate custom tracks for the UCSC Genome Browser (http://genome.ucsc.edu/). Peak finding, motif finding, and peak annotation were performed using HOMER. Peaks were assigned to gene targets based on the closest RefSeq defined TSS. Randomizations were performed during the HOMER motif finding algorithm. These involved selecting random fragments of genomic DNA to be used as control regions for motif discovery. Randomly selected fragments of DNA were selected to normalize GC% content.
Statistical analyses. Standard deviation and Student's t test and one-way ANOVA were performed with the Prism 4 program. P < 0.05 was considered significant. Unpaired t test was used for comparisons between control and transgenic mice within one group and between control and HD samples. Data are presented as mean ± s.d. For each experiment, a minimum sample size of three biological replicates was analyzed in each experimental condition. No statistical methods were used to pre-determine sample sizes, but our sample sizes are similar to those generally employed in the field. The estimate of the variance within each group was calculated and found to be similar between groups that were being statistically compared.
